The hospital has introduced the MONARCH™ platform, which allows physicians to navigate a flexible endoscope deep into the lungs with greater stability, control and precision.
The network plans to scale diabetes care using a “clinic within a clinic” approach, enabling patients to access integrated and convenient services for chronic disease management.
The minimally invasive technology enables doctors to monitor patients remotely and identify changes in their condition before symptoms become severe.
Schizophrenia is a chronic and complex mental health disorder that can significantly affect patients, their families and caregivers when inadequately managed.
Researchers found that women who delivered prematurely consumed significantly lower amounts of protein, vitamins and essential minerals than those who carried their pregnancies to term.
This highly specific dependence could provide an opportunity for researchers to investigate new approaches to malaria treatment by targeting the parasite’s ability to obtain or use these fats.
Under the agreement, SGH-referred healthcare practitioners will have access to DataFlow’s range of services, including Premium PSV, VIP Assist, Document Concierge, licensing and credentialing support, digital footprint checks and Prometric nursing exam training.
The findings, generated using patient-derived stem cells and advanced brain models, could support the development of targeted therapies for Huntington’s disease, which progressively damages movement, cognitive function and behavioural control.
The accreditation covers Fakeeh Health, including FUH and its network of Fakeeh Medical Centers, and recognizes the organization as an approved institution for PGME training in the UAE.
Aster DM Healthcare was represented by Rahul Kadavakolu, Group Chief Marketing Officer, while Boehringer Ingelheim was represented by Ousama Alhaj, General Manager and Head of Human Pharma for the Near East and UAE, alongside Ghaleb Al Ahdab, Head of Public and Government Affairs for the Near East and UAE.